pharma news today obesity drugs glp-1 september 2025 Giants Bet on Next-Generation Treatments to Sustain Growth As weight loss drugs like

The accountability, encouragement, and shared experience may improve adherence enough to offset the higher cost

Research design note: Studies investigating body composition changes should specify whether the primary endpoint is total weight, fat mass, lean mass, or waist circumference, as the compounds differ most clearly on total and adipose-specific outcomes

4 GLP-1 Theories on Regeneration and Proliferation The exact mechanism of GLP-1 binding to GLP-1 receptor coupled with beta cell release of insulin is unknown

Many of our Naples GLP-1 patients discover that combining their weight loss program with testosterone therapy or peptide treatments accelerates their progress and helps them feel more energized, focused, and confident throughout their transformation

Study found that increasing endogenous and exogenous intestinal SCFAs can stimulate intestinal endocrine cells to secrete GLP-1 and PYY by binding to GPR41 and GPR43 (Tian et al., 2024)

In comparison with the overweight/obese reference group, which had a rate of major birth defects of 3.9%, the adjusted OR was 0.54 (95% CI, 0.11 to 2.75)